Table 1 Grade of malignancy (1 = low, 2 = high/intermediate), subjective view of change in symptoms between pretreatment stage (E1) and after first chemotherapy cycle (E2) (0 = unchanged, 1 = relieved).
From: Non-Hodgkin lymphoma response evaluation with MRI texture classification
Patient | Grade of malignity | Symptoms | Volume | ||
|---|---|---|---|---|---|
1 = low 2 = high/intermediate | 0 = unchanged 1 = relieved | E1 (cm3) | E2 (cm3) | Change% | |
1 | 2 | 1 | 429 | 105 | -76% |
2 | 2 | 1 | 183 | 64 | -65% |
3 | 1 | 1 | 173 | 66 | -62% |
4 | 1 | 1 | 529 | 459 | -13% |
5 | 1 | 0 | 570 | 419 | -26% |
6 | 1 | 1 | 800 | 595 | -26% |
7 | 2 | 1 | 146 | 118 | -19% |
8 | 2 | 0 | 118 | 80 | -32% |
9 | 1 | 1 | 367 | 246 | -33% |
10 | 1 | 0 | 850 | 769 | -10% |
11 | 2 | 1 | 2144 | 1622 | -24% |
12 | 2 | 1 | 72 | 30 | -58% |
13 | 2 | 0 | 140 | 52 | -63% |
14 | 2 | 1 | 274 | 93 | -66% |
15 | 1 | 1 | 795 | 190 | -76% |
16 | 1 | 0 | 824 | 797 | -3% |
17 | 1 | 0 | 750 | 579 | -23% |
18 | 1 | 0 | 273 | 66 | -76% |
19 | 1 | 0 | 771 | 522 | -32% |